NEW YORK ( TheStreet) -- CHANGE IN RATINGSBGC Partners ( BGCP) downgraded at KBW to Market Perform from Outperform, Keefe, Bruyette & Woods said. Valuation call, based on an $8 price target. Cavium ( CAVM) upgraded at Jefferies to Buy from Hold, Jefferies said. $44 price target. Checks show multiple design wins. Cloud Peak Energy ( CLD) upgraded at BMO to Outperform from Market Perform, BMO Capital Markets said. $22 price target. Attractive coal contract position. CryptoLogic ( CRYP) upgraded to hold at TheStreet Ratings. DR Horton ( DHI) upgraded at Credit Suisse to Outperform, Credit Suisse said. $17.25 price target. Buyer traffic is improving across the industry. Energy Services of America ( ESA) upgraded to hold at TheStreet Ratings. Georgia Gulf ( GGC) upgraded at Wells from Market Perform to Outperform, Wells Fargo said. Estimates also boosted, given better construction demand. Green Mountain ( GMCR) downgraded at BofA/Merrill to Neutral, Bank of America/Merrill Lynch said. SBUX offering could create new competition. $63 price target. Health Management ( HMA) rated new Hold at Cantor Fitzgerald. $8 price target. Near-term hospital activity could remain sluggish. Intersil ( ISIL)upgraded at Craig Hallum to Buy from Hold, Craig Hallum said. $14 price target. Confident the worst is behind the company. JP Morgan ( JPM) rated new Buy at Guggenheim. $50 price target. Company should continue to boost buyback and dividend activity. Kohl's ( KSS) upgraded at Jefferies to Buy from Hold, Jefferies said. $59 price target. A bet on management and other tailwinds. Lennar ( LEN) upgraded at Credit Suisse from Neutral to Outperform, Credit Suisse said. Buyer traffic has been strong across the industry. $28.75 price target. Lifepoint Hospitals ( LPNT) rated new Buy at Cantor Fitzgerald. $44 price target. Earnings growth is accelerating and the company deserves a higher multiple. Medicis ( MRX) upgraded at Goldman to Buy, Goldman Sachs said. $43 price target. Company is focused on generating new growth. Pall ( PLL) downgraded at Wedbush to Neutral from Outperform, Wedbush said. $64 price target. Upside appears modest from here. Toll Brothers ( TOL) upgraded at Credit Suisse from Neutral to Outperform, Credit Suisse said. $28 price target. Industry checks show improving fundamentals. Volcano ( VOLC) upgraded at Goldman from Neutral to Buy, Goldman Sachs said. $36 price target. FFR business should drive growth over the coming quarters.